Health Center

Ads & Resources

Comprehensive Health Directory

Manage Patient Records

Home » Neurology

Neurology Videos « Go Back

Stemedica Requests Pre-IND Meeting With FDA

Posted By: Anonymous | Posted On: Aug 20,2009 18:30 pm | View: 14 Stemedica Cell Technologies, Inc. USA, a leader in adult stem cell research and manufacturing, has requested a pre-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration ("FDA") to discuss a proposed IND to use Stemedica's proprietary line of allogeneic mesenchymal bone marrow cells (adult human) as a treatment for ischemic stroke. Read More: http://www.prweb.com/releases/Stemedica-Stroke/PRE-IND-FDA/prweb2776804.htm

Other Health Sources

About Us | Contact Us | Asthma | Cancer | Cardiology | Diabetes | Neurology | Diet & Nutrition | Pediatrics | OB/GYN | General

Copyright © 2008-2012, DoctorsOutlook.com, All Rights Reserved.

Disclaimer: Issuers of the submissions/postings are solely responsible for the content of their submissions. Doctorsoutlook.com can't be held liable for the contents of these submissions. In case any submission damages your benefits or violate your rights in any way, please contact us and we'll remove it immediately.